BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 16781946)

  • 1. Cardioprotection by adiponectin.
    Ouchi N; Shibata R; Walsh K
    Trends Cardiovasc Med; 2006 Jul; 16(5):141-6. PubMed ID: 16781946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin actions in the cardiovascular system.
    Hopkins TA; Ouchi N; Shibata R; Walsh K
    Cardiovasc Res; 2007 Apr; 74(1):11-8. PubMed ID: 17140553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of adiponectin as a cardioprotective agent.
    Shibata R; Ouchi N; Walsh K; Murohara T
    Future Cardiol; 2007 Nov; 3(6):647-56. PubMed ID: 19804285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac-derived adiponectin induced by long-term insulin treatment ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic mice via AMPK signaling.
    Pei H; Qu Y; Lu X; Yu Q; Lian K; Liu P; Yan W; Liu J; Ma Y; Liu Y; Li C; Li W; Lau WB; Zhang H; Tao L
    Basic Res Cardiol; 2013 Jan; 108(1):322. PubMed ID: 23262803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms.
    Shibata R; Sato K; Pimentel DR; Takemura Y; Kihara S; Ohashi K; Funahashi T; Ouchi N; Walsh K
    Nat Med; 2005 Oct; 11(10):1096-103. PubMed ID: 16155579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of adiponectin in the development of high fat diet-induced metabolic abnormalities in mice.
    Hecker PA; O'Shea KM; Galvao TF; Brown BH; Stanley WC
    Horm Metab Res; 2011 Feb; 43(2):100-5. PubMed ID: 21165812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress.
    Tao L; Gao E; Jiao X; Yuan Y; Li S; Christopher TA; Lopez BL; Koch W; Chan L; Goldstein BJ; Ma XL
    Circulation; 2007 Mar; 115(11):1408-16. PubMed ID: 17339545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin and interleukin-6 in inflammation-associated disease.
    Li L; Wu LL
    Vitam Horm; 2012; 90():375-95. PubMed ID: 23017723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
    Matsuda M; Shimomura I
    Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment.
    Shibata R; Sato K; Kumada M; Izumiya Y; Sonoda M; Kihara S; Ouchi N; Walsh K
    Cardiovasc Res; 2007 Jun; 74(3):471-9. PubMed ID: 17362898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin replenishment ameliorates obesity-related hypertension.
    Ohashi K; Kihara S; Ouchi N; Kumada M; Fujita K; Hiuge A; Hibuse T; Ryo M; Nishizawa H; Maeda N; Maeda K; Shibata R; Walsh K; Funahashi T; Shimomura I
    Hypertension; 2006 Jun; 47(6):1108-16. PubMed ID: 16651465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin and cardiovascular disease: response to therapeutic interventions.
    Han SH; Quon MJ; Kim JA; Koh KK
    J Am Coll Cardiol; 2007 Feb; 49(5):531-8. PubMed ID: 17276175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin and hypertension.
    Ohashi K; Ouchi N; Matsuzawa Y
    Am J Hypertens; 2011 Mar; 24(3):263-9. PubMed ID: 20930707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased myocardial ischemia-reperfusion injury in renal failure involves cardiac adiponectin signal deficiency.
    Song Y; Yu Q; Zhang J; Huang W; Liu Y; Pei H; Liu J; Sun L; Yang L; Li C; Li Y; Zhang F; Qu Y; Tao L
    Am J Physiol Endocrinol Metab; 2014 May; 306(9):E1055-64. PubMed ID: 24595307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin as an anti-inflammatory factor.
    Ouchi N; Walsh K
    Clin Chim Acta; 2007 May; 380(1-2):24-30. PubMed ID: 17343838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia inducible factor-1 upregulates adiponectin in diabetic mouse hearts and attenuates post-ischemic injury.
    Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):178-87. PubMed ID: 18287886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of adiponectin in inflamed adipose tissues of obese mice.
    Nakatsuji H; Kishida K; Sekimoto R; Komura N; Kihara S; Funahashi T; Shimomura I
    Metabolism; 2014 Apr; 63(4):542-53. PubMed ID: 24467915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.